Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells

Neuropeptides

Volumn 43, Issue 2, 2009, Pages 53-61

  Falktoft, Birgitte ^a   Georg, Birgitte ^a   Fahrenkrug, Jan ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chinese hamster ovary cells; co immunoprecipitation; FOS; G protein coupled receptors; Gene expression; Neuropeptides; Protein interaction; Signaling; W 5; W 7

Indexed keywords

CALCIUM; CALMODULIN; DUAL SPECIFICITY PHOSPHATASE 2; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PROTEIN FOS; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NERVE CONDUCTION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN MOTIF; REAL TIME POLYMERASE CHAIN REACTION;

CALMODULIN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SIGNAL TRANSDUCTION; TIME FACTORS;

CRICETULUS GRISEUS;

EID: 62949089891     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.02.001     Document Type: Article

References (54)

1. Akiyama M., Minami Y., Nakajima T., Moriya T., and Shibata S. Calcium and pituitary adenylate cyclase-activating polypeptide induced expression of circadian clock gene mPer1 in the mouse cerebellar granule cell culture. J. Neurochem. 78 (2001) 499-508
2. Bofill-Cardona E., Kudlacek O., Yang Q., Ahorn H., Freissmuth M., and Nanoff C. Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J. Biol. Chem. 275 (2000) 32672-32680
3. Braas K.M., Schutz K.C., Bond J.P., Vizzard M.A., Girard B.M., and May V. Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons. Peptides 28 (2007) 1856-1870
4. Cauvin A., Buscail L., Gourlet P., De Neef P., Gossen D., Arimura A., Miyata A., Coy D.H., Robberecht P., and Christophe J. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 11 (1990) 773-777
5. Dautzenberg F.M., and Hauger R.L. G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology 40 (2001) 394-407
6. Delcourt N., Thouvenot E., Chanrion B., Galéotti N., Jouin P., Bockaert J., and Marin P. PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons. EMBO J. 26 (2007) 1542-1551
7. Ehlers M.D., Zhang S., Bernhadt J.P., and Huganir R.L. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84 (1996) 745-755
8. Fahrenkrug J., Hannibal J., Honoré B., and Vorum H. Altered calmodulin response to light in the suprachiasmatic nucleus of PAC1 receptor knockout mice revealed by proteomic analysis. J. Mol. Neurosci. 25 (2005) 251-258
9. Georg B., and Fahrenkrug J. Pituitary adelylate cyclase-activating peptide is an activator of vasoactive intestinal polypeptide gene transcription in human neuroblastoma cells. Brain Res.: Mol. Brain Res. 79 (2000) 67-76
10. Georg B., Hannibal J., and Fahrenkrug J. Lack of the PAC1 receptor alters the circadian expression of VIP mRNA in the suprachiasmatic nucleus of mice. Brain Res. 1135 (2007) 52-57
11. Grumolato L., Elkahloun A.G., Ghzili H., Alexandre D., Coulouarn C., Yon L., Salier J.P., Eiden L.E., Fournier A., Vaudry H., and Anouar Y. Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology 144 (2003) 2368-2379
12. Hannibal J., Jamen F., Nielsen H.S., Journot L., Brabet P., and Fahrenkrug J. Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J. Neurosci. 21 (2001) 4883-4890
13. Hannibal J., Georg B., and Fahrenkrug J. Melanopsin changes in neonatal albino rat independent of rods and cones. Neuroreport 18 (2007) 81-85
14. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., and Waschek J.A. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50 (1998) 265-270
15. Hayez N., Harfi I., Lema-Kisoka R., Svoboda M., Corazza F., and Sariban E. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells. J. Neuroimmunol. 149 (2004) 167-181
16. Hidaka H., Sasaki Y., Tanaka T., Endo T., Ohno S., Fujii Y., and Nagata T. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc. Natl. Acad. Sci. USA 78 (1981) 4354-4357
17. Honrado G.I., Johnson R.S., Golombek D.A., Spiegelman B.M., Papaioannou V.E., and Ralph M.R. The circadian system of c-fos deficient mice. J. Comp. Physiol. [A] 178 (1996) 563-570
18. Igarashi H., Ito T., Hou W., Mantey S.A., Pradhan T.K., Ulrich II C.D., Hocart S.J., Coy D.H., and Jensen R.T. Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig. J. Pharmacol. Exp. Ther. 301 (2002) 37-50
19. Ishido M., and Masuo Y. Transcriptome of pituitary adenylate cyclase-activating polypeptide-differentiated PC12 cells. Regul. Peptides 123 (2004) 15-21
20. Kawaguchi C., Tanaka K., Isojima Y., Shintani N., Hashimoto H., Baba A., and Nagai K. Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem. Biophys. Res. Commun. 310 (2003) 169-175
21. Kornhauser J.M., Nelson D.E., Mayo K.E., and Takahashi J.S. Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 5 (1990) 127-134
22. 2+]i increase but not adenylate cyclase stimulation. Cell. Signal. 17 (2005) 17-24
23. Langer I., Langlet C., and Robberecht P. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor. J. Mol. Endocrinol. 34 (2005) 405-414
24. Lebon A., Seyer D., Cosette P., Coquet L., Jouenne T., Chan P., Leprince J., Fournier A., Vaudry H., Gonzalez B.J., and Vaudry D. Identification of proteins regulated by PACAP in PC12 cells by 2D gel electrophoresis coupled to mass spectrometry. Ann. NY Acad. Sci. 1070 (2006) 380-387
25. Li H., and Villalobo A. Evidence for the direct interaction between calmodulin and the human epidermal growth factor receptor. Biochem. J. 362 (2002) 499-505
26. Li H., Ruano M.J., and Villalobo A. Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. FEBS Lett. 559 (2004) 175-180
27. Liu Y., Buck D.C., Macey T.A., Lan H., and Neve K.A. Evidence that calmodulin binding to the dopamine D2 receptor enhances receptor signaling. J. Recept. Signal Transduct. Res. 27 (2007) 47-65
28. Llovera M., de Pablo Y., Egea J., Encinas M., Peiró S., Martín-Zanca D., Rocamora N., and Comella J.X. Trk is a calmodulin-binding protein: implications for receptor processing. J. Neurochem. 88 (2004) 422-433
29. Lyu R.M., Germano P.M., Choi J.K., Le S.V., and Pisegna J.R. Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization. J. Biol. Chem. 275 (2000) 36134-36142
30. MacDonald J.F., Jackson M.F., and Beazely M.A. G protein-coupled receptors control NMDARs and metaplasticity in the hippocampus. Biochim. Biophys. Acta 1768 (2007) 941-951
31. Mahon M.J., and Shimada M. Calmodulin interacts with the cytoplasmic tails of the parathyroid hormone 1 receptor and a sub-set of class b G-protein coupled receptors. FEBS Lett. 579 (2005) 803-807
32. Mangels L.A., and Gnegy M.E. Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells. Brain Res.: Mol. Brain Res. 12 (1992) 103-110
33. Marie J.C., Rouyer-Fessard C., Couvineau A., Nicole P., Devaud H., El Benna J., and Laburthe M. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor. Mol. Pharmacol. 64 (2003) 1565-1574
34. Martin J.L., Gasser D., and Magistretti P.J. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons. J. Neurochem. 65 (1995) 1-9
35. Murthy K.S., and Makhlouf G.M. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide-dependent activation of membrane-bound NO synthase in smooth muscle mediated by pertussis toxin-sensitive Gi1-2. J. Biol. Chem. 269 (1994) 15977-15980
36. Murthy K.S., Mahavadi S., Huang J., Zhou H., and Sriwai W. Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle. Am. J. Physiol. - Cell Physiol. 294 (2008) C477-C487
37. Nachtergael I., Gaspard N., Langlet C., Robberecht P., and Langer I. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor. Cell. Signal. 18 (2006) 2121-2130
38. Nickols H.H., Shah V.N., Chazin W.J., and Limbird L.E. Calmodulin interacts with the V2 vasopressin receptor: elimination of binding to the C terminus also eliminates arginine vasopressin-stimulated elevation of intracellular calcium. J. Biol. Chem. 279 (2004) 46969-46980
39. Rajagopal R., Chen Z.Y., Lee F.S., and Chao M.V. Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J. Neurosci. 24 (2004) 6650-6658
40. Ravni A., Bourgault S., Lebon A., Chan P., Galas L., Fournier A., Vaudry H., Gonzalez B., Eiden L.E., and Vaudry D. The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. J. Neurochem. 98 (2006) 321-329
41. Ravni A., Eiden L.E., Vaudry H., Gonzalez B.J., and Vaudry D. Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation. J. Neurochem. 98 (2006) 1229-1241
42. Sallese M., Iacovelli L., Cumashi A., Capobianco L., Cuomo L., and De Blasi A. Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins. Biochim. Biophys. Acta 1498 (2000) 112-121
43. Sanggaard K.M., Hannibal J., and Fahrenkrug J. Serotonin inhibits glutamate- but not PACAP-induced per gene expression in the rat suprachiasmatic nucleus at night. Eur. J. Neurosci. 17 (2003) 1245-1252
44. Schäfer H., Zheng J., Gundlach F., Günther R., Siegel E.G., Fölsch U.R., and Schmidt W.E. Pituitary adenylate-cyclase-activating polypeptide stimulates proto-oncogene expression and activates the AP-1 (c-Fos/c-Jun) transcription factor in AR4-2J pancreatic carcinoma cells. Eur. J. Biochem. 242 (1996) 467-476
45. Schulz S., Röcken C., Mawrin C., Weise W., Höllt V., and Schulz S. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clin. Cancer Res. 10 (2004) 8235-8242
46. Sengupta P., Ruano M.J., Tebar F., Golebiewska U., Zaitseva I., Enrich C., McLaughlin S., and Villalobo A. Membrane-permeable calmodulin inhibitors (e.g. W-7/W-13) bind to membranes, changing the electrostatic surface potential: dual effect of W-13 on epidermal growth factor receptor activation. J. Biol. Chem. 282 (2007) 8474-8486
47. Shetzline M.A., Walker J.K., Valenzano K.J., and Premont R.T. Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestration. J. Biol. Chem. 277 (2002) 25519-25526
48. 2+/calmodulin-binding domain within the carboxyl-terminus of the angiotensin II (AT1A) receptor. FEBS Lett. 455 (1999) 367-371
49. Turner J.H., and Raymond J.R. Interaction of calmodulin with the serotonin 5-hydroxytryptamine2A receptor. A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C. J. Biol. Chem. 280 (2005) 30741-30750
50. Turner J.H., Gelasco A.K., and Raymond J.R. Calmodulin interacts with the third intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct sites: putative role in receptor phosphorylation by protein kinase C. J. Biol. Chem. 279 (2004) 17027-17037
51. Vaudry D., Basille M., Anouar Y., Fournier A., Vaudry H., and Gonzalez B.J. The neurotrophic activity of PACAP on rat cerebellar granule cells is associated with activation of the protein kinase A pathway and c-fos gene expression. Ann. NY Acad. Sci. 865 (1998) 92-99
52. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52 (2000) 269-324
53. Vertongen P., Camby I., Darro F., Kiss R., and Robberecht P. VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Neuropeptides 30 (1996) 491-496
54. Yap K.L., Kim J., Truong K., Sherman M., Yuan T., and Ikura M. Calmodulin target database. J. Struct. Funct. Genomics 1 (2000) 8-14